Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1777 participants.

Also called NCT02040441

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose diagnostic
Phase
Phase 2/3
Enrolled
  • 1,777 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02040441
  • EudraCT 2012-000452-34
Other papers using this trial's data
  • Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial Journal of diabetes and its complications, 2023-04 DOI, PubMed 36841085

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Czechia, Denmark, Germany, Greece, Italy, Netherlands, North Macedonia, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02040441. Randomized; quadruple masking; primary purpose diagnostic. Start 2014-03 (actual); primary completion 2018-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Acronym
PRIORITY
Condition
Diabetic Nephropathy
Condition
Diabetic Retinopathy
Intervention (Drug)
Spironolactone
Intervention (Drug)
Placebo
Intervention (Drug)
Standard care
Lead sponsor
Peter Rossing (class: other)
Collaborator
Mosaiques Diagnostics GmbH (class: not stated)
Collaborator
University Medical Center Groningen (class: other)
Collaborator
University of Glasgow (class: other)
Collaborator
Istituto Di Ricerche Farmacologiche Mario Negri (class: other)
Collaborator
Univerzita Karlova v Praze (class: other)
Collaborator
Geniko Nosokomeio Athinas Ippokrateio (class: not stated)
Collaborator
Institut Klinické a Experimentální Mediciny Praze (class: not stated)
Collaborator
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (class: other)
Collaborator
Klinikum St. Georg Leipzig (class: not stated)
Collaborator
Ss. Cyril and Methodius University of Skopje (class: other)
Collaborator
Hannover Clinical Trial Center (class: not stated)
Collaborator
European Commission (class: other)
Collaborator
Diabetes Vascular Research Foundation Hoogeveen (class: not stated)
Collaborator
University Ghent (class: other)
Collaborator
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden (class: not stated)
Collaborator
Stichting VUMC (class: not stated)
Collaborator
Diabetologen Hessen (class: not stated)

Record details

Record id
cardio:ct-nct02040441
Content hash
20cbf5d789c30162113a073eb1fc14f2e3e5b9f4bd17acdf41f51ccccba08f97